Literature DB >> 6138932

Adrenergic control of lipid metabolism.

U Smith.   

Abstract

Adrenergic receptors are ubiquitous and mediate several important effects involving lipid metabolism. Thus, beta-adrenergic stimulation increases lipolysis and inhibits the activity of the lipoprotein lipase. In contrast, alpha-adrenergic stimulation inhibits fat cell lipid mobilisation. Unexpectedly, beta-adrenergic blockade increases plasma triglyceride levels and tends to lower the high density lipoprotein (HDL-cholesterol). These effects seem to be prevented or attenuated by concomitant alpha-blockade. Possible mechanisms for the adrenergic effect on lipid metabolism are reviewed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138932     DOI: 10.1111/j.0954-6820.1983.tb01612.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  8 in total

Review 1.  Exercise metabolism and beta-blocker therapy. An update.

Authors:  A Head
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.136

Review 2.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

3.  Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist.

Authors:  K Lange Andersen; W Piatkowski; K A Green; W Ottmann
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

4.  Lipid profiles of persons with paraplegia and tetraplegia: sex differences.

Authors:  Andreas Schmid; Judith Knöebber; Stefan Vogt; Daniel König; Peter Deibert; Dirk Bültermann; Lothar Heinrich; Manfred W Baumstark; Aloys Berg; Max-Jürgen Storch
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

5.  Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Comparison between a beta 1-selective and a non-selective beta blocker.

Authors:  F T Verstappen; M A van Baak
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987

6.  Reduced ambulatory heart rate response to physical work and complaints of fatigue among hypertensive males treated with beta-blockers.

Authors:  E Kristal-Boneh; S Melamed; J Bernheim; I Peled; M S Green
Journal:  J Behav Med       Date:  1995-04

Review 7.  GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer.

Authors:  Darakhshan Sohail Ahmed; Stéphane Isnard; John Lin; Bertrand Routy; Jean-Pierre Routy
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

8.  Influence of b2 adrenergic receptor polymorphism (rs1042713 and rs1042714) on anthropometric, hormonal and lipid profiles in polycystic ovarian syndrome.

Authors:  Maha H Daghestani; Maha Omair; Mazin Daghestani; Sonya S Abdel-Razeq; Namik Kaya; Arjumand Warsy
Journal:  J Med Biochem       Date:  2021-01-26       Impact factor: 3.402

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.